Literature DB >> 8942886

Particle size and drug interactions of injectable corticosteroids used in ophthalmic practice.

B A Francis1, E L Chang, B G Haik.   

Abstract

PURPOSE: The aim of this study is to compare the particle sizes of commercially available corticosteroids for intralesional injection to manufacturers' specifications and to evaluate changes in size when mixed with other steroids and other commonly used solutions.
METHODS: The particle sizes of dexamethasone sodium phosphate, methylprednisolone acetate, triamcinolone acetonide, and betamethasone sodium phosphate and beta-methasone acetate were measured with the Coulter counter. Each steroid was mixed with each of the others, lidocaine, and lidocaine with epinephrine, then measured immediately and after 1 hour to determine the effect on particle size.
RESULTS: All steroids showed accurate manufacturer specifications. Dexamethasone showed an increase in particle size when mixed with lidocaine alone, immediately and after 1 hour. Triamcinolone showed an increase in particle size only after 1 hour after mixture with lidocaine alone. Triamcinolone, dexamethasone, and methylprednisolone particles increased in size when mixed with lidocaine and epinephrine. Dexamethasone and triamcinolone showed an additional increase in size when allowed to sit for 1 hour after mixture with lidocaine and epinephrine. Mixing steroids caused no increase in particle size.
CONCLUSION: Because an increase in the number of particles greater than 20 microns in a solution also increases the likelihood of vascular occlusion, the authors urge care in the mixing of these drugs, especially with lidocaine and epinephrine. If mixture is necessary, the authors recommend that injection take place immediately subsequent.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8942886     DOI: 10.1016/s0161-6420(96)30411-9

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  7 in total

1.  Pressure measurements during injection of corticosteroids.

Authors:  S Paul; J E Egbert; A W Walsh; M F Hoey
Journal:  Med Biol Eng Comput       Date:  1998-11       Impact factor: 2.602

2.  Pressure measurements during injection of corticosteroids: in vivo studies.

Authors:  S Paul; M F Hoey; J E Egbert
Journal:  Med Biol Eng Comput       Date:  1999-09       Impact factor: 2.602

3.  The role of anti-inflammatory agents in age-related macular degeneration (AMD) treatment.

Authors:  Y Wang; V M Wang; C-C Chan
Journal:  Eye (Lond)       Date:  2010-12-24       Impact factor: 3.775

Review 4.  Paraplegia complicating selective steroid injections of the lumbar spine. Report of five cases and review of the literature.

Authors:  Marc Wybier; Sandrine Gaudart; David Petrover; Emmanuel Houdart; Jean-Denis Laredo
Journal:  Eur Radiol       Date:  2009-08-14       Impact factor: 5.315

Review 5.  Medication Trends for Age-Related Macular Degeneration.

Authors:  Yeon-Kyoung Cho; Dae-Hun Park; In-Chul Jeon
Journal:  Int J Mol Sci       Date:  2021-10-31       Impact factor: 5.923

6.  Delineating Injectable Triamcinolone-Induced Cutaneous Atrophy and Therapeutic Options in 24 Patients-A Retrospective Study.

Authors:  Reena K Sharma; Mudita Gupta; Ritu Rani
Journal:  Indian Dermatol Online J       Date:  2022-03-03

Review 7.  Ophthalmic drug dosage forms: characterisation and research methods.

Authors:  Przemysław Baranowski; Bożena Karolewicz; Maciej Gajda; Janusz Pluta
Journal:  ScientificWorldJournal       Date:  2014-03-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.